pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,853 catalysts · 5,627 phase readout · 2,210 8k filing · 226 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 0 catalysts2026-08-04: 0 catalysts2026-08-05: 0 catalysts2026-08-06: 18 catalysts2026-08-07: 2 catalysts2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 3 catalysts2026-08-11: 3 catalysts2026-08-12: 3 catalysts2026-08-13: 3 catalysts2026-08-14: 1 catalyst2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 2 catalysts2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 1 catalyst2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 0 catalysts2026-10-27: 3 catalysts2026-10-28: 5 catalysts2026-10-29: 10 catalysts2026-10-30: 3 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: grant×type: earnings×clear all
type
  • phase readout5,627
  • 8k filing2,210
  • earnings226
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT06829784: TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection

Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.. Phase: PHASE3. Conditions: Asthma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07532733: Respiratory and Haemodynamic Effects of Conscious Sedation With Dexmedetomidine for a TAVI Procedure

Sponsor: Erasme University Hospital. Phase: NA. Conditions: TAVI(Transcatheter Aortic Valve Implantation)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07502352: Remotely-Delivered Cognitive Behavioral Stress Management for Breast Cancer (R-CBSM)

Sponsor: University of Miami. Phase: NA. Conditions: Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06947538: Stepped Care for Posttraumatic Stress Disorder Study

Sponsor: Boston Medical Center. Phase: NA. Conditions: Post Traumatic Stress Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07350252: Combination of Nerve Blocks and Local Infiltration Analgesia in Knee Arthroplasty

Sponsor: Region Skane. Phase: PHASE4. Conditions: Osteo Arthritis of the Knee

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03770338: Preoperative Teriparatide Use on Insertional Torque of Pedicle Screws for Lumbar Fusion Surgery

Sponsor: The University of Hong Kong. Phase: NA. Conditions: Osteoporosis, Fusion of Spine, Lumbar Region

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06899958: Metabolism Enhancement by Laser Therapy

Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Metabolism Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07664826: Acupuncture Mechanism in Relief of Gag Reflex

Sponsor: University Medicine Greifswald. Phase: NA. Conditions: Gag (Pharyngeal) Reflex

full page →ctgov ↗
›RECRUITINGphase readoutNCT05833555: Harlem Strong Mental Health Coalition

Sponsor: City University of New York, School of Public Health. Phase: NA. Conditions: Stress-related Problem, Depression, Anxiety, Mental Health Wellness

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05944926: Improving Outcomes in Depression in Primary Care in a Low Resource Setting

Sponsor: Harvard Medical School (HMS and HSDM). Phase: PHASE3. Conditions: Depression, Depressive Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT06702878: Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections

Sponsor: Ondine Biomedical Inc.. Phase: PHASE3. Conditions: Surgical Site Infections, Surgical Wound Infection, Infections, Anti-Infective Agents

full page →ctgov ↗
›RECRUITINGphase readoutNCT06446765: Mindfulness-based Neurofeedback to Augment Psychotherapy for Adults With Borderline Personality Disorder

Sponsor: Yale University. Phase: PHASE2. Conditions: Borderline Personality Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT04188067: TMS for the Treatment of Primary Progressive Aphasia

Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Logopenic Variant Primary Progressive Aphasia, Non-fluent Variant Primary Progressive Aphasia, Semantic Variant Primary Progressive Aphasia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07374367: Isthmin-1 as a Biomarker of Disease Activity in Rheumatoid Arthritis: Correlation With Musculoskeletal Ultrasound Findings

Sponsor: Amera Imam Abdel - Ghany Ahmed. Phase: . Conditions: Disease Activity

full page →ctgov ↗
›RECRUITINGphase readoutNCT07696000: The Effect of Structured Medical Nutrition Therapy on Systemic Inflammation Index in Patients With Schizophrenia Receiving Antipsychotic Therapy

Sponsor: DINA KEUMALA SARI. Phase: NA. Conditions: Schizophrenia / Schizoaffective Disorder

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07566208: Using Mirabegron to Control Arrhythmia-1

Sponsor: Cedars-Sinai Medical Center. Phase: PHASE2. Conditions: Ventricular Arrhythmias and Cardiac Arrest

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07484035: Safety and Efficacy Evaluation of an Extensively Hydrolyzed Formula in Infants With Cow's Milk Protein Allergy (CMPA)

Sponsor: Heilongjiang Feihe Dairy Co. Ltd.. Phase: NA. Conditions: Cow's Milk Protein Allergy (CMPA)

full page →ctgov ↗
›RECRUITINGphase readoutNCT04074135: Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: VHL Pancreatic Neuroendocrine Tumors, Von Hippel-Lindau Disease, Neuroendocrine Tumors

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07345117: Cost-effectiveness and Implementation of a Transdiagnostic Internet-based Intervention for Emotional Disorders in Community Care.

Sponsor: Universitat Jaume I. Phase: NA. Conditions: Emotional Disorders, Depression Anxiety Disorder, Depression Disorders, Anxiety Disorders

full page →ctgov ↗
›COMPLETEDphase readoutNCT02603640: " Virtual Brain "-Based Interpretation of Electrophysiological Signals in Epilepsy

Sponsor: Assistance Publique Hopitaux De Marseille. Phase: NA. Conditions: Epilepsy

full page →ctgov ↗
›COMPLETEDphase readoutNCT07087340: Early Feasibility Evaluation of the UniBE Hybrid Closed-loop Insulin Delivery System in Type 1 Diabetes: UBLoop-Genesis

Sponsor: University of Bern. Phase: NA. Conditions: Type-1-Diabetes

full page →ctgov ↗
›RECRUITINGphase readoutNCT06507150: AI-assisted Migraine Education: Efficacy, Safety and Patients' Acceptance

Sponsor: Ente Ospedaliero Cantonale, Bellinzona. Phase: NA. Conditions: Migraine

full page →ctgov ↗
›COMPLETEDphase readoutNCT05628350: Highly Processed Foods and Vascular Health

Sponsor: Virginia Polytechnic Institute and State University. Phase: NA. Conditions: Cardiovascular Diseases

full page →ctgov ↗
›RECRUITINGphase readoutNCT07185191: Evaluation of the Safety and Performance of the Medical Device RDM36 in the Treatment of Periodontal Gingival Contraction and in Black Triangles Syndrome (BTS)

Sponsor: Mastelli S.r.l. Phase: NA. Conditions: Black Triangles Syndrome (BTS), Periodontal Gingival Contraction

full page →ctgov ↗
›COMPLETEDphase readoutNCT07052890: Curcumin, Vitamin D and Green Tea in IBS-D

Sponsor: Dr Anthony Hobson. Phase: NA. Conditions: Irritable Bowel Syndrome (IBS), Irritable Bowel Syndrome With Diarrhea (IBS-D)

full page →ctgov ↗
›RECRUITINGphase readoutNCT05960890: Cohort Study of Chronic Heart Failure

Sponsor: Jiangsu Taizhou People's Hospital. Phase: NA. Conditions: Heart Failure

full page →ctgov ↗
›COMPLETEDphase readoutNCT04593810: Effect of Automated Closed-Loop Ventilation Versus Conventional Ventilation on Duration and Quality of Ventilation

Sponsor: Prof. Dr. Marcus J. Schultz. Phase: NA. Conditions: Ventilator-free Days, Quality of Breathing

full page →ctgov ↗
›COMPLETEDphase readoutNCT02213913: Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas

Sponsor: University of Chicago. Phase: PHASE1. Conditions: Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Progressive Hairy Cell Leukemia, Initial Treatment, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Stage 0 Chronic Lymphocytic Leukemia, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Small Lymphocytic Lymphoma, Stage II Adult Hodgkin Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Small Lymphocytic Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Small Lymphocytic Lymphoma, Testicular Lymphoma, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia

›COMPLETEDphase readoutNCT05911360: A Study to Evaluate Efficacy, Safety and Tolerability in Antiretroviral Therapy (ART)-Experienced Participants of at Least 50 Years of Age Living With Human Immunodeficiency Virus (HIV) With Virologic Suppression Who Switch to DTG/3TC FDC From BIC/FTC/TAF

Sponsor: ViiV Healthcare. Phase: PHASE3. Conditions: HIV, HIV Infections

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07498660: PRP Injection Into the Sacroiliac Joint After Ipsilateral THA: Effects on Early Recovery and Function (SIJ-THA Randomized Trial)

Sponsor: Medical University of Warsaw. Phase: NA. Conditions: Osteoarthitis, Sacro Iliac Joint Pain, Hip Arthroplasty, Total, Sacro-Iliac Spondylosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07684820: To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

Sponsor: Expedition Therapeutics, Inc. Phase: PHASE2. Conditions: Chronic Obstructive Pulmonary Disease (COPD)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02629120: High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamide for Patients With Chronic Granulomatous Disease

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE1. Conditions: Chronic Granulomatous Disease Transplant

full page →ctgov ↗
›RECRUITINGphase readoutNCT07310420: A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast Cancer

Sponsor: TerSera Therapeutics LLC. Phase: PHASE1. Conditions: Advanced Breast Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07617220: FIRST-Sask Study Protocol: A Remote Exercise Oncology Intervention

Sponsor: University of Saskatchewan. Phase: NA. Conditions: Exercise Oncology

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07399782: Botulinum Toxin in the Palatopharyngeal Muscle for the Treatment of Obstructive Sleep Apnea

Sponsor: Hospital Felicio Rocho. Phase: PHASE2. Conditions: Sleep Apnea Syndrome, Obstructive, Sleep Apnea Syndrome (OSAS), Sleep Apnea/Hypopnea Syndrome, Sleep Apnea - Obstructive

full page →ctgov ↗
›COMPLETEDphase readoutNCT07202182: Creative Drama-Based Stress Management Program on Stress, Coping, and Emotional Intelligence

Sponsor: Gazi University. Phase: NA. Conditions: Emotional Intelligence, Creative Drama, Coping, Nursing, Undergraduate

full page →ctgov ↗
›RECRUITINGphase readoutNCT06239259: Validity and Reliability of Thai Version Clinical Questionnaire for Diagnosis of Carpal Tunnel Syndrome

Sponsor: Siriraj Hospital. Phase: . Conditions: Carpal Tunnel Syndrome

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07575659: Early Intervention in Cerebral Palsy: Perception-Action vs Neurodevelopmental Therapy

Sponsor: Tuba Derya Doğan. Phase: NA. Conditions: Cerebral Palsy, Cerebral Palsy Early Intervention

full page →ctgov ↗
›RECRUITINGphase readoutNCT06048159: Transcranial Alternating Current Stimulation (tACS) for the Recovery of Phonological Short-Term Memory in Patients With Aphasia After Stroke

Sponsor: Medical College of Wisconsin. Phase: NA. Conditions: Stroke, Aphasia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07743359: Enhancing Delivery of Parenting Support Within a Peer Recovery Support Service Model

Sponsor: Baystate Medical Center. Phase: NA. Conditions: Substance Use Disorders (SUDs)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07275580: Antibiotic Prophylaxis After Simple Tooth Extraction in Immunosuppressed Patients With Autoimmune Rheumatic Diseases

Sponsor: University of Sao Paulo General Hospital. Phase: PHASE4. Conditions: Autoimmune Rheumatic Diseases, Tooth Extraction, Infection Prevention, Antibiotic Prophylaxis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06629779: A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

Sponsor: Pfizer. Phase: PHASE3. Conditions: Metastatic Castration-Resistant Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06095596: Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University. Phase: NA. Conditions: Ulcerative Colitis (UC)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07581496: T1G3R-1 Trial: Detectability and Prognostic Value of ctDNA in T1 G3 Bladder Cancer

Sponsor: University Hospital, Basel, Switzerland. Phase: . Conditions: Bladder Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06857279: A Phase II Clinical Study to Evaluate HLX43 in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Sponsor: Shanghai Henlius Biotech. Phase: PHASE2. Conditions: Carcinoma of Head and/or Neck

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06433596: Autologous PRP and Focal Shock Waves for Erectile Dysfunction

Sponsor: Elexial Research Limited. Phase: NA. Conditions: Erectile Dysfunction

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07438262: The AminoECMO Pilot Trial

Sponsor: Australian and New Zealand Intensive Care Research Centre. Phase: PHASE2. Conditions: Acute Kidney Injury

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03997162: Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric Cancer Undergoing Surgery

Sponsor: City of Hope Medical Center. Phase: . Conditions: Clinical Stage 0 Gastric Cancer AJCC v8, Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage IIA Gastric Cancer AJCC v8, Clinical Stage IIB Gastric Cancer AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, Gastric Adenocarcinoma, Pathologic Stage 0 Gastric Cancer AJCC v8, Pathologic Stage I Gastric Cancer AJCC v8, Pathologic Stage IA Gastric Cancer AJCC v8, Pathologic Stage IB Gastric Cancer AJCC v8, Pathologic Stage II Gastric Cancer AJCC v8, Pathologic Stage IIA Gastric Cancer AJCC v8, Pathologic Stage IIB Gastric Cancer AJCC v8, Pathologic Stage III Gastric Cancer AJCC v8, Pathologic Stage IIIA Gastric Cancer AJCC v8, Pathologic Stage IIIB Gastric Cancer AJCC v8, Pathologic Stage IIIC Gastric Cancer AJCC v8

full page →ctgov ↗
›COMPLETEDphase readoutNCT05393362: Effectiveness of a Cardiac Rehabilitation Program in Elderly Patients With Heart Failure.

Sponsor: University of Malaga. Phase: NA. Conditions: Heart Failure With Preserved Ejection Fraction, Sarcopenia, Frail Elderly Syndrome, Comorbidities and Coexisting Conditions

full page →ctgov ↗
›COMPLETEDphase readoutNCT05598788: Microsampling Approach for Monitoring of Kinase Inhibitor Targeted Therapies

Sponsor: Rennes University Hospital. Phase: . Conditions: Blood Concentrations of Nine Anti-cancer Drugs : Axitinib, Olaparib, regorafénib, Cabozantinib, Niraparib, Talazoparib, Palbociclib, Abemaciclib, Tucatinib

full page →ctgov ↗
← prev
page 116 of 118
next →
full page →ctgov ↗